Dechra Pharmaceuticals PLC/ GB0009633180 /
| 9/29/2023 5:29:45 PM | Chg. -1.00 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3,797.00GBX | -0.03% | 9,904 Turnover(GBP): 376,271.4000 |
-Bid Size: - | -Ask Size: - | 4.1 bill.GBP | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.54 GBP | 4.62% |
| EPS Diluted: | - GBP | 3.86% |
| Revenues per Share: | 6.29 GBP | 11.86% |
| Book Value per Share: | 6.15 GBP | 5.09% |
| Cash Flow per Share: | 1.13 GBP | 37.59% |
| Dividend per Share: | 0.45 GBP | 10.84% |
| Total | in mill. | |
| Revenues: | 681.80 GBP | 12.14% |
| Net Income: | 58.20 GBP | 4.86% |
| Operating Cash Flow: | 122.90 GBP | - |
| Cash and Cash Equivalents: | 120.90 GBP | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 70.38 | 64.43 |
| P/S Ratio: | 6.01 | 5.50 |
| P/BV ratio: | 6.14 | 5.62 |
| P/CF Ratio: | 33.33 | 30.52 |
| PEG: | 15.24 | 13.95 |
| Earnings Yield: | 1.42% | 1.55% |
| Dividend Yield: | 1.19% | 1.30% |
| Market Capitalization | ||
| Market Capitalization: | 4.1 bill. GBP | 3.75 bill. GBP |
| Free Float Market Cap.: | - GBP | - GBP |
| Market Cap. / Employee: | 2.01 mill. GBP | 1.84 mill. GBP |
| Shares Outstanding: | 108.22 mill. | |
Profitability
| Gross Profit Margin: | 56.44% |
| EBIT Margin: | 14.01% |
| Net Profit Margin: | 8.54% |
| Return on Equity: | 8.73% |
| Return on Assets: | 4.50% |
Financial Strength
| Liquidity I / Cash Ratio: | 76.18% |
| Liquidity II / Quick Ratio: | 162.38% |
| Liquidity III / Current Ratio: | 280.03% |
| Debt / Equity Ratio: | 0.00% |
| Dynam. Debt / Equity Ratio: | - |
Efficiency
| Employees: | 2,036 |
| Personal Expenses / Employee: | - GBP |
| Revenues / Employee: | 334,872.30 GBP |
| Net Income / Employee: | 28,585.46 GBP |
| Total Assets / Employee: | 635,216.11 GBP |
| * Fiscal Year End: | 6/30/2022 |
| Accounting Standard: | IFRS |
| Currency: | GBP |